Skip to content

Goodwill at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$6.96B+8.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$9.12B+3.1%
NeoGenomics logo
NeoGenomicsNEO
$524M+0.2%
Veracyte logo
VeracyteVCYT
$767.15M+1.7%
Guardant Health logo
Guardant HealthGH
$77.26M+2,248%
Natera, Inc. logo
Natera, Inc.NTRA
$140.86M

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's goodwill?
Myriad Genetics (MYGN) reported goodwill of $47.1M in Q1 2026.
How has Myriad Genetics's goodwill changed year-over-year?
Myriad Genetics's goodwill decreased by 83.5% year-over-year, from $286.3M to $47.1M.
What is the long-term trend for Myriad Genetics's goodwill?
Over 5 years (2020 to 2025), Myriad Genetics's goodwill has grown at a -31.0% compound annual growth rate (CAGR), from $329.2M to $51.6M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.